Indianapolis, IN, United States of America

David E Magee

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David E Magee. Retrieved from https://idiyas.com/inventor/david-e-magee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David E Magee: Innovator in Pharmaceutical Solutions

Introduction

David E Magee is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on aqueous solution inclusion complexes.

Latest Patents

David E Magee holds 1 patent for his invention titled "Aqueous solution inclusion complexes of benzothiophene compounds." This patent provides aqueous inclusion complexes of certain known benzothiophene compounds, particularly Raloxifene, and water-soluble cyclodextrins. The invention also includes pharmaceutical compositions of such inclusion complexes and methods for using these complexes to inhibit bone loss and reduce serum cholesterol in mammals.

Career Highlights

David is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work focuses on developing innovative solutions that address critical health issues.

Collaborations

David has collaborated with esteemed colleagues, including Henry U Bryant and George J Cullinan, to advance research and development in the pharmaceutical sector.

Conclusion

David E Magee's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through scientific research and development. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…